Top Story

Surgeons perform first gene therapy procedure aimed at stopping AMD-related blindness

February 19, 2019

Eyenovia enrolling broad patient population in MicroProst phase 3 trial

February 19, 2019
Eyenovia will include a broad patient population, including patients with chronic angle closure glaucoma, open-angle glaucoma and ocular hypertension, in a phase 3 trial…

Wage-fixing and no-poach agreements

February 19, 2019
Antitrust laws are intended to ensure that firms compete fairly in an open marketplace, including to hire or retain employees. Physician practices that agree with each…
Meeting News

Combination of PRK, cross-linking shows good results over 4 years

February 19, 2019
ATHENS, Greece — A combination of PRK and accelerated corneal cross-linking, called PRK Xtra, may be a way to perform refractive surgery in eyes with suspicious…

BLOG: MGD heats up: J&J lowers LipiFlow cost

February 18, 2019
Some 5 years after I first made the suggestion, the new owners of the TearScience suite of meibomian gland dysfunction treatments — LipiView, LipiScan, LipiFlow…
More Headlines »
Clinical ScienceOpen Access

A New Suggested Strategy for Safe Injection of Ozurdex

Ophthalmic Surgery, Lasers and Imaging Retina, February 2019, Volume 50 Issue 2
Ozurdex intravitreal injection is performed via a patented injection device. However, there is a common misconception…
More »

Cataract and Refractive 360—Fundamentals, Techniques, & Technology; Volume 3, Number 4

This activity is supported by educational grants from Alcon Laboratories, Inc.; Bausch + Lomb; Carl Zeiss Meditec, Inc.; and J & J Vision.

Successful cataract surgery involves a multifactorial process that relies on numerous interconnected assessment…
More »
Resource Centers
Meeting News

VIDEO: Consider resistance severity in glaucoma treatment decisions

February 9, 2019
More »